Early physiological phenotypes and survival outcomes in advanced non-small cell lung cancer: a longitudinal study of dynamic muscle loss and functional decline
Objective To characterize early changes in skeletal muscle and physical function among patients with advanced non-small cell lung cancer (NSCLC) receiving penpulimab monotherapy or combination therapy, and to identify distinct treatment-associated physiological phenotypes with potential clinical relevance. Methods We r...